We need to get the EFS started but that depends on the FDA. I talked to IR last week and they were very nice but couldn't answer any of my questions about the EFS timeline or study design because they obviously can't disclose nonpublic info. My impression was that it still may be a little while until the EFS is announced but it still could be seen as imminent depending on what your definition of imminent is. That was just my impression, I was given no specific info on it.
It also sounded like Nasdaq is not as far along as the EFS and that internal decisions still have to be made on that timeline. I wish I could remember exactly what Dejan told me but it was to that effect.
As for the share price, I'd double my position if it got near 10 bucks but my guess is that this will probably be higher lows to go with the recent higher highs.
We need to get the EFS started but that depends on the FDA. I...
Add to My Watchlist
What is My Watchlist?
